Professor and Chair of Pathology and Laboratory Medicine at the University of Rochester Medical Center, Dr. Smoller is a widely published and respected clinician, teacher, and international expert in dermatopathology.
Dr. Smoller's career has canvassed medical schools affiliated with Harvard, Stanford, Cornell, and the University of Arkansas. More recently, he served a term as executive vice president and secretary-treasurer for the 10,000-member United States and Canadian Academy of Pathology while simultaneously holding a faculty post at both Georgia Regents University (formerly Georgia Health Sciences University) and the Emory University School of Medicine.
Dr. Smoller belongs to a number of professional societies, including the American Society of Dermatopathology, where he took a turn as president and as a board member; the American Society of Clinical Pathologists; and the College of American Pathologists. Smoller spent five years as editor-in-chief of the Journal of Cutaneous Pathology and is frequently tapped for input on editorial boards for other preeminent journals in dermatology, pathology, and dermatopathology. Dr. Smoller has authored more than 200 peer-reviewed articles in leading journals plus 13 textbooks.
His primary research interests revolve around cutaneous T cell lymphoma and the role of immunopathology as a diagnostic tool.
Dr. Burack is the Vice Chair for Clinical Operations in the Department of Pathology and Laboratory Medicine. He directs the Hematopathology division, which includes the Flow Cytometry Laboratory, tissue banking activities, and the Hematopathology Fellowship Program. This division works closely with Wilmot Cancer Institute and Pediatric Oncology to evaluate and diagnose lymphomas, leukemias, and related disorders. Burack also directs the Molecular Genetic Pathology unit, which includes laboratories conducting diagnostic genetic tests, such as DNA sequencing and chromosomal analyses. Molecular Genetic Pathology supports the care of patients throughout the medical center, from Wilmot to Obstetrics.
Dr. Burack's research interests include the molecular mechanisms of lymphoma progression and development of molecular methods to refine diagnostics, particularly of lymphomas and leukemias.
Dr. Victoria Zhang is the Vice Chair for Clinical Enterprise Strategy and Associate Professor of Pathology and Laboratory Medicine. She also serves as the Medical Director of Ambulatory Lab Services, Director of the Regional Toxicology and Mass Spectrometry Laboratory, and Associate Director of Clinical Chemistry at URMC.
She earned her PhD in Biochemistry and Bioinformatics from the University of Minnesota. Zhang later completed a clinical chemistry fellowship at Harvard Medical School and received her MBA from The Wharton School at University of Pennsylvania. She has served in numerous leadership positions for U.S. and international organizations including the American Association of Clinical Chemistry (AACC) for which she founded the Mass Spectrometry and Separation Sciences (MSSS) division.
Her research interests include clinical applications of mass spectrometry, toxicology, test utilization, transitioning of late phase discovery and -omics biomarkers to clinical services, and biomarkers for early diagnoses using -omics technologies.
Scott A. Kirkley, M.D. is Vice Chair for Pathology Education, Associate Director of the Transfusion Medicine Service and Program Director of the URMC Pathology Residency Training Program. He serves as Associate Professor of Pathology and Laboratory Medicine. His clinical interests include establishing transfusion protocols and helping coordinate laboratory services in support of organ transplantation programs at Strong Memorial Hospital. He is accredited in Blood Banking and Transfusion Medicine, Anatomic Pathology, and Clinical Pathology by the American Board of Pathology; and in Internal Medicine by American Board of Internal Medicine.
He received his medical degree at SUNY Upstate Medical Center, Syracuse, after earning a bachelor’s degree in Biochemistry at Syracuse University. His post-doctoral training includes a fellowship in Transfusion Medicine at Hoxworth Blood Center in Cincinnati, OH, a residency in Anatomic and Clinical Pathology at Deaconess Hospital in Boston, MA, and a residency and internship in Internal Medicine at Danbury Hospital in Danbury, CT.
Dr. Kirkley’s research has focused on the suppressive effects of allogeneic (homologous) blood transfusion on the immune system, and comparing the effects of allogeneic, autologous, and leukoreduced transfusions on immune function.